|
Alemtuzumab
|
Visite: 219
|
|
Altretamine
|
Visite: 424
|
|
Aminoglutetimide
|
Visite: 393
|
|
L'Acido 5-Aminolevulinico
|
Visite: 325
|
|
Idrossicarbamide
|
Visite: 230
|
|
Anastrozole
|
Visite: 395
|
|
Arsenico Triossido Di
|
Visite: 396
|
|
Asparaginasi
|
Visite: 349
|
|
Bevacizumab
|
Visite: 263
|
|
Bexarotene
|
Visite: 404
|
|
Bleomicina
|
Visite: 388
|
|
Busulfan
|
Visite: 355
|
|
Capecitabina
|
Visite: 367
|
|
Carboplatino
|
Visite: 418
|
|
Carmustina
|
Visite: 413
|
|
Cetuximab
|
Visite: 270
|
|
Ciclofosfamide
|
Visite: 384
|
|
Cisplatino
|
Visite: 257
|
|
La citarabina
|
Visite: 245
|
|
Cladribina
|
Visite: 254
|
|
Chlorambucil
|
Visite: 397
|
|
Chlormethinum
|
Visite: 525
|
|
Dacarbazina
|
Visite: 206
|
|
Dactinomicina
|
Visite: 271
|
|
Daunorubicina
|
Visite: 219
|
|
Docetaxel
|
Visite: 205
|
|
Doxorubicina
|
Visite: 429
|
|
Epirubucin
|
Visite: 214
|
|
Erlotinib
|
Visite: 337
|
|
Etoposide
|
Visite: 262
|
|
Exemestano
|
Visite: 410
|
|
Fluorouracile Topico Soluzione
|
Visite: 194
|
|
Fluorouracile
|
Visite: 265
|
|
Gemcitabina
|
Visite: 200
|
|
Idarubicina-Hcl
|
Visite: 361
|
|
Ifosfamide
|
Visite: 224
|
|
Melfalan
|
Visite: 199
|
|
Mercaptopurina
|
Visite: 341
|
|
Methotrexate
|
Visite: 297
|
|
Mitomicina
|
Visite: 306
|
|
Mitoxantrone
|
Visite: 190
|
|
Oxaliplatino
|
Visite: 179
|
|
Paclitaxel
|
Visite: 239
|
|
Pentostatina
|
Visite: 245
|
|
Procarbazina
|
Visite: 237
|
|
Rituximab
|
Visite: 267
|
|
Teniposide
|
Visite: 202
|
|
Tioguanina
|
Visite: 185
|
|
Tiotepa
|
Visite: 197
|
|
Trastuzumab
|
Visite: 252
|
|
Tretinoin Orale
|
Visite: 384
|
|
Vinblastina
|
Visite: 207
|
|
Vincristina
|
Visite: 195
|
|
Vinorelbine Tartrate
|
Visite: 227
|
|
Everolimus
|
Visite: 229
|
|
Imatinib Mesilato
|
Visite: 217
|
|
Nilotinib
|
Visite: 260
|
|
Dasatinib
|
Visite: 220
|
|
Pazopanib
|
Visite: 195
|
|
Ipilimumab
|
Visite: 197
|
|
Nivolumab
|
Visite: 232
|
|
Brentuximab Vedotin
|
Visite: 224
|